KIR2DL3 antibody has been tested by ELISA and Western blot immunofluorescent staining with flow cytometric analysis to assure specificity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Applications include flow cytometry (5-10g/1:1000000), ELISA (1:1,000 when tested against the immunized protein) and western blot analysis (1ug/ml).

Mouse IgG2a heavy chains and κ light chain.

Anti-human KIR2DL3 mAb, is derived from hybridization of mouse P3-x63-Ag8.653 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human KIR2DL3 amino acids 19-161 purified from E. coli.

1mg/ml containing PBS, pH-7.4, & 0.1% Sodium Azide.

KIR2DL3 antibody was purified from mouse ascitic fluids by protein-G affinity chromatography.

12 months at -20^oC. 1 month at 4^oC

For periods up to 1 month store at 4^oC, for longer periods of time, store at -20^oC. Prevent freeze thaw cycles.

Killer cell immunoglobulin-like receptor 2DL3, MHC class I NK cell receptor, Natural killer-associated transcript 2, NKAT-2, NKAT2a, NKAT2b, p58 natural killer cell receptor clone CL-6, p58 NK receptor, p58.2 MHC class-I-specific NK receptor, Killer inhibitory receptor cl 2-3, KIR-023GB, CD158 antigen-like family member B2, CD158b2 antigen, KIR2DL3, CD158B2, KIRCL23, NKAT2, p58, NKAT, GL183, CD158b, KIR-K7b, KIR-K7c, MGC129943.

Mouse Anti Human Monoclonal.